Published in Malar J on June 16, 2010
Shrinking the malaria map: progress and prospects. Lancet (2010) 8.21
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
Malaria rapid diagnostic tests in elimination settings--can they find the last parasite? Clin Microbiol Infect (2011) 1.98
Call to action: priorities for malaria elimination. Lancet (2010) 1.85
Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change. Malar J (2011) 1.50
Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics. Adv Parasitol (2014) 1.44
Outdoor malaria transmission in forested villages of Cambodia. Malar J (2013) 1.37
Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme. Malar J (2012) 1.32
Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J Clin Invest (2012) 1.31
Continuing intense malaria transmission in northern Uganda. Am J Trop Med Hyg (2011) 1.30
School-based surveys of malaria in Oromia Regional State, Ethiopia: a rapid survey method for malaria in low transmission settings. Malar J (2011) 1.29
Malaria transmission and vector behaviour in a forested malaria focus in central Vietnam and the implications for vector control. Malar J (2010) 1.26
Serology for trachoma surveillance after cessation of mass drug administration. PLoS Negl Trop Dis (2015) 1.21
Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidence. Malar J (2015) 1.17
Serological measures of malaria transmission in Haiti: comparison of longitudinal and cross-sectional methods. PLoS One (2014) 1.14
Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009. Malar J (2014) 1.14
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A (2015) 1.13
Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti. Malar J (2014) 1.09
Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies. Malar J (2013) 1.07
Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands. BMC Infect Dis (2012) 1.07
Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J Infect Dis (2014) 1.07
Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia. Malar J (2013) 1.03
Reliability of school surveys in estimating geographic variation in malaria transmission in the western Kenyan highlands. PLoS One (2013) 1.03
Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis. BMC Med (2014) 1.02
Serologically defined variations in malaria endemicity in Pará state, Brazil. PLoS One (2014) 1.02
Assessing malaria transmission in a low endemicity area of north-western Peru. Malar J (2013) 1.02
Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands. Malar J (2012) 0.99
Filter paper collection of Plasmodium falciparum mRNA for detecting low-density gametocytes. Malar J (2012) 0.99
Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey. PLoS One (2015) 0.98
Serology describes a profile of declining malaria transmission in Farafenni, The Gambia. Malar J (2015) 0.95
Dramatic declines in seropositivity as determined with crude extracts of Plasmodium falciparum schizonts between 2000 and 2010 in Dielmo and Ndiop, Senegal. Malar J (2014) 0.95
Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep (2014) 0.94
Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax. PLoS One (2011) 0.93
Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation. Malar J (2014) 0.92
Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity. Malar J (2015) 0.91
Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection. Am J Trop Med Hyg (2015) 0.89
Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination. Malar J (2016) 0.89
Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity. Sci Rep (2016) 0.87
Application of Serological Tools and Spatial Analysis to Investigate Malaria Transmission Dynamics in Highland Areas of Southwest Uganda. Am J Trop Med Hyg (2016) 0.86
Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication. J Immunol Res (2015) 0.84
Use of different transmission metrics to describe malaria epidemiology in the highlands of western Kenya. Malar J (2015) 0.84
Integration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15-39 Years of Age in Cambodia. PLoS Negl Trop Dis (2016) 0.84
Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate. Malar J (2015) 0.83
Geostatistical modeling of malaria endemicity using serological indicators of exposure collected through school surveys. Am J Trop Med Hyg (2015) 0.82
Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE. Acta Trop (2014) 0.81
Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models. Malar J (2016) 0.80
Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal. Malar J (2015) 0.80
Serological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity. Parasit Vectors (2015) 0.79
Temporal and spatial patterns of serologic responses to Plasmodium falciparum antigens in a region of declining malaria transmission in southern Zambia. Malar J (2012) 0.79
Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar J (2015) 0.79
Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J (2016) 0.78
Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance. J Leukoc Biol (2016) 0.78
The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia. Malar J (2017) 0.77
Micro-epidemiological structuring of Plasmodium falciparum parasite populations in regions with varying transmission intensities in Africa. Wellcome Open Res (2017) 0.76
Impact of metric and sample size on determining malaria hotspot boundaries. Sci Rep (2017) 0.75
Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting. BMC Infect Dis (2017) 0.75
A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection. Malar J (2017) 0.75
The value of local malaria strains for serological studies: local strains versus Palo Alto reference strain. Malar J (2015) 0.75
Seroprevalence of Antibodies against Plasmodium falciparum Sporozoite Antigens as Predictive Disease Transmission Markers in an Area of Ghana with Seasonal Malaria Transmission. PLoS One (2016) 0.75
Spatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers. Clin Infect Dis (2017) 0.75
Serological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu. Parasit Vectors (2017) 0.75
Using Respondent Driven Sampling to Identify Malaria Risks and Occupational Networks among Migrant Workers in Ranong, Thailand. PLoS One (2016) 0.75
A comparison of Plasmodium falciparum circumsporozoite protein-based slot blot and ELISA immuno-assays for oocyst detection in mosquito homogenates. Malar J (2015) 0.75
Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination. Malar J (2017) 0.75
Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar. Infect Dis Poverty (2016) 0.75
A longitudinal cohort study of malaria exposure and changing serostatus in a malaria endemic area of rural Tanzania. Malar J (2017) 0.75
The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg (2001) 11.74
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun (2008) 3.51
Malaria eradication on islands. Lancet (2000) 3.51
Seroepidemiological evidence of eradication of malaria from Mauritius. Lancet (1973) 3.16
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Malaria in São Tomé and principe: on the brink of elimination after three years of effective antimalarial measures. Am J Trop Med Hyg (2009) 2.83
The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J (2009) 2.66
Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog (2010) 2.30
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J (2007) 2.30
Endemicity response timelines for Plasmodium falciparum elimination. Malar J (2009) 2.29
Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun (2008) 2.18
The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg (1997) 2.12
Community participation for malaria elimination in Tafea Province, Vanuatu: Part I. Maintaining motivation for prevention practices in the context of disappearing disease. Malar J (2010) 2.04
Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol (2009) 1.96
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS One (2010) 1.87
The Toxoplasma homolog of Plasmodium apical membrane antigen-1 (AMA-1) is a microneme protein secreted in response to elevated intracellular calcium levels. Mol Biochem Parasitol (2000) 1.74
Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg (1975) 1.58
Malaria on the Amazonian frontier: transmission dynamics, risk factors, spatial distribution, and prospects for control. Am J Trop Med Hyg (2008) 1.55
Serological malaria surveys in Nigeria. Bull World Health Organ (1968) 1.55
Changing patterns in the humoral immune response to malaria before, during, and after the application of control measures: a longitudinal study in the West African savanna. Bull World Health Organ (1978) 1.47
Erythrocyte invasion by Babesia bovis merozoites is inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1. Infect Immun (2004) 1.43
Spatiotemporal patterns of malaria incidence in northern Thailand. Trans R Soc Trop Med Hyg (2006) 1.43
Baseline spatial distribution of malaria prior to an elimination programme in Vanuatu. Malar J (2010) 1.37
Relationship between entomological inoculation rate, Plasmodium falciparum prevalence rate, and incidence of malaria attack in rural Gabon. Acta Trop (2003) 1.31
Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum. J Infect Dis (2003) 1.25
Cross-reactivity between antibodies in the sera of individuals with leishmaniasis, toxoplasmosis, and Chagas' disease and antigens of the blood-stage forms of Plasmodium falciparum determined by indirect immunofluorescence. Am J Trop Med Hyg (1995) 1.21
Malaria transmission pattern resilience to climatic variability is mediated by insecticide-treated nets. Malar J (2008) 1.14
Malaria imported into Réunion Island: is there a risk of re-emergence of the disease? Trans R Soc Trop Med Hyg (2009) 1.10
Moderate transmission but high prevalence of malaria in Madagascar. Int J Parasitol (2006) 1.01
Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes? Malar J (2006) 1.00
A longitudinal study of Plasmodium falciparum malaria in the West African savannah using the ELISA technique. Bull World Health Organ (1980) 0.98
Immunophoretic rapid diagnostic tests as a source of immunoglobulins for estimating malaria sero-prevalence and transmission intensity. Malar J (2009) 0.98
[Longitudinal sero-epidemiologic study of malaria in Tunisia]. Bull World Health Organ (1976) 0.98
Measles serological survey in the Italian population: interpretation of results using mixture model. Vaccine (2008) 0.97
Analysis of rubella antibody distribution from newborn dried blood spots using finite mixture models. Epidemiol Infect (2008) 0.97
An innovative database for epidemiological field studies of neglected tropical diseases. PLoS Negl Trop Dis (2009) 0.97
Logistic discrimination of mixtures of M. tuberculosis and non-specific tuberculin reactions. Stat Med (2001) 0.97
Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. Mem Inst Oswaldo Cruz (2007) 0.96
Malaria in the Pare area of Tanzania. IV. Malaria in the human population 11 years after the suspension of residual insecticide spraying, with special reference to the serological findings. Trans R Soc Trop Med Hyg (1972) 0.91
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ (2004) 11.96
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ (2007) 10.03
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med (2012) 4.68
Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis (2005) 4.58
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA (2005) 4.57
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (2010) 3.90
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One (2010) 3.50
The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. Malar J (2006) 3.31
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol (2006) 2.45
A qualitative study on the acceptability and preference of three types of long-lasting insecticide-treated bed nets in Solomon Islands: implications for malaria elimination. Malar J (2009) 2.33
Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania. Malar J (2004) 2.25
Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. Elife (2013) 2.17
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One (2007) 2.17
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother (2010) 2.15
Spatial epidemiology of Plasmodium vivax, Afghanistan. Emerg Infect Dis (2006) 2.09
Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care*. Pediatr Crit Care Med (2013) 2.08
Community participation for malaria elimination in Tafea Province, Vanuatu: Part I. Maintaining motivation for prevention practices in the context of disappearing disease. Malar J (2010) 2.04
The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination. Malar J (2011) 1.88
Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS One (2012) 1.81
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J (2010) 1.77
Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care. JACC Cardiovasc Interv (2011) 1.75
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci (2008) 1.73
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda. Malar J (2014) 1.73
The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg (2003) 1.69
Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar J (2013) 1.64
Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania. Malar J (2011) 1.63
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (2002) 1.60
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One (2012) 1.57
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J (2013) 1.57
Malaria elimination: moving forward with spatial decision support systems. Trends Parasitol (2012) 1.54
Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis (2010) 1.53
Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J (2008) 1.51
Assessing the genetic diversity of the aldolase genes of Plasmodium falciparum and Plasmodium vivax and its potential effect on performance of aldolase-detecting rapid diagnostic tests. J Clin Microbiol (2006) 1.45
Variation in duration of respiratory support among Australian and New Zealand pediatric intensive care units. Pediatr Crit Care Med (2011) 1.45
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J (2011) 1.42
Active case detection for malaria elimination: a survey among Asia Pacific countries. Malar J (2013) 1.39
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine. Malar J (2011) 1.38
Efficacy of pyrethroid-treated nets against malaria vectors and nuisance-biting mosquitoes in Tanzania in areas with long-term insecticide-treated net use. Trop Med Int Health (2007) 1.38
Baseline spatial distribution of malaria prior to an elimination programme in Vanuatu. Malar J (2010) 1.37
Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J (2012) 1.35
Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study. Am J Kidney Dis (2008) 1.31
A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. AIDS Care (2008) 1.30
Continuing intense malaria transmission in northern Uganda. Am J Trop Med Hyg (2011) 1.30
Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania. BMC Infect Dis (2009) 1.29
Novel vectors of malaria parasites in the western highlands of Kenya. Emerg Infect Dis (2012) 1.26
Operational research to inform a sub-national surveillance intervention for malaria elimination in Solomon Islands. Malar J (2012) 1.25
Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS One (2012) 1.24
Malaria elimination in Isabel Province, Solomon Islands: establishing a surveillance-response system to prevent introduction and reintroduction of malaria. Malar J (2011) 1.24
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J (2010) 1.23
Spatiotemporal analysis of indigenous and imported dengue fever cases in Guangdong province, China. BMC Infect Dis (2012) 1.21
Geographical information systems for dengue surveillance. Am J Trop Med Hyg (2012) 1.20
Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach. Am J Trop Med Hyg (2005) 1.20
Malaria risk factors in North West Tanzania: the effect of spraying, nets and wealth. PLoS One (2013) 1.17
The impact of hotspot-targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled trial. Trials (2013) 1.17
A typology of penile cutting in Papua New Guinea: results of a modified Delphi study among sexual health specialists. AIDS Care (2011) 1.16
Dengue fever and El Nino/Southern Oscillation in Queensland, Australia: a time series predictive model. Occup Environ Med (2009) 1.16
"Now we are in a different time; various bad diseases have come." Understanding men's acceptability of male circumcision for HIV prevention in a moderate prevalence setting. BMC Public Health (2012) 1.16
Functional reinnervation of the canine bladder after spinal root transection and immediate somatic nerve transfer. J Neurotrauma (2008) 1.16
A cluster randomized controlled cross-over bed net acceptability and preference trial in Solomon Islands: community participation in shaping policy for malaria elimination. Malar J (2009) 1.16
Community participation for malaria elimination in Tafea Province, Vanuatu: part II. Social and cultural aspects of treatment-seeking behaviour. Malar J (2011) 1.15
The effect of insecticide synergists on the response of scabies mites to pyrethroid acaricides. PLoS Negl Trop Dis (2009) 1.14
Malaria transmission pattern resilience to climatic variability is mediated by insecticide-treated nets. Malar J (2008) 1.14
Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis (2013) 1.14
Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J (2014) 1.14
Combined spatial prediction of schistosomiasis and soil-transmitted helminthiasis in Sierra Leone: a tool for integrated disease control. PLoS Negl Trop Dis (2012) 1.14
Mapping malaria risk in Bangladesh using Bayesian geostatistical models. Am J Trop Med Hyg (2010) 1.13
Intravaginal and menstrual practices among women working in food and recreational facilities in Mwanza, Tanzania: implications for microbicide trials. AIDS Behav (2010) 1.13
Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania. PLoS One (2009) 1.12
Assessing agreement between malaria slide density readings. Malar J (2010) 1.12
Acaricidal activity of eugenol based compounds against scabies mites. PLoS One (2010) 1.11
Encysted seizures: status epilepticus in a recently resettled refugee child. Med J Aust (2010) 1.11
The plasticity of Plasmodium falciparum gametocytaemia in relation to age in Burkina Faso. Malar J (2010) 1.11
Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol (2008) 1.10
Sexual risk behaviour for women working in recreational venues in Mwanza, Tanzania: considerations for the acceptability and use of vaginal microbicide gels. Cult Health Sex (2009) 1.10
A high-resolution geospatial surveillance-response system for malaria elimination in Solomon Islands and Vanuatu. Malar J (2013) 1.10